For this Case Assignment, you are part of a medical research team and are tasked with gaining informed consent from potential participants. The study will seek to test an experimental drug with patients suffering from late-stage leukemia. The sample will be divided into a control group and the experimental group. Participants in the control group will be given a placebo, which could increase the progression of their disease. The sample will be composed of children.
Discuss how you would go about seeking the consent of participants.
Your paper will be evaluated based on the rubric criteria
Atac, A., et al. (2005). A Study of the Opinions and Behaviors of Physicians with Regard to Informed Consent and Refusing Treatment. Military Medicine, 170(7), 566-71.
Brudney, D. (2009, Mar./Apr.). Choosing for another: beyond autonomy and best interests. The Hastings Center Report. 39(2), 31-38.
Dickman, R. L. (2000, March). Bending the rules to get a medication. American Family Physician 61 (5), 1563. http://www.aafp.org/afp/2000/0301/p1563.html
Erlen, J. A. (2010). Informed consent: Revisiting the issues. Orthopaedic Nursing, 29(4), 276-80. Retrieved from
Lambert, V., & Glacken, M. (2011). Engaging with children in research: Theoretical and practical implications of negotiating informed consent/assent.Nursing Ethics, 18(6), 781-801. doi: http://dx.doi.org/10.1177/0969733011401122
Miller, F. G., & Wertheimer, A. (2011). The fair transaction model of informed consent: An alternative to autonomous authorization. Kennedy Institute of Ethics Journal, 21(3), 201-18. Retrieved from Waller, B. N., & Repko, R. A. (2008). Informed consent: Good medicine, dangerous side effects. Cambridge Quarterly of Healthcare Ethics, 17(1), 66-74.